A comparative study of circulating biomarkers of anti-VEGF therapy in phase II trials in advanced hepatocellular carcinoma (HCC) patients (pts).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lipika Goyal, Marek Ancukiewicz, Rakesh K. Jain, Andrew X. Zhu, Dan G. Duda
Institution: Massachusetts General Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598320796